Literature DB >> 19214178

Greater omentectomy improves insulin sensitivity in nonobese dogs.

Maya Lottati1, Cathryn M Kolka, Darko Stefanovski, Erlinda L Kirkman, Richard N Bergman.   

Abstract

Visceral adiposity is strongly associated with insulin resistance; however, little evidence directly demonstrates that visceral fat per se impairs insulin action. Here, we examine the effects of the surgical removal of the greater omentum and its occupying visceral fat, an omentectomy (OM), on insulin sensitivity (S(I)) and beta-cell function in nonobese dogs. Thirteen male mongrel dogs were used in this research study; animals were randomly assigned to surgical treatment with either OM (n = 7), or sham-surgery (SHAM) (n = 6). OM failed to generate measurable changes in body weight (+2%; P = 0.1), or subcutaneous adiposity (+3%; P = 0.83) as assessed by magnetic resonance imaging (MRI). The removal of the greater omentum did not significantly reduce total visceral adipose volume (-7.3 +/- 6.4%; P = 0.29); although primary analysis showed a trend for OM to increase S(I) when compared to sham operated animals (P = 0.078), further statistical analysis revealed that this minor reduction in visceral fat alleviated insulin resistance by augmenting S(I) of the periphery (+67.7 +/- 35.2%; P = 0.03), as determined by the euglycemic-hyperinsulinemic clamp. Insulin secretory response during the hyperglycemic step clamp was not directly influenced by omental fat removal (presurgery 6.82 +/- 1.4 vs. postsurgery: 6.7 +/- 1.2 pmol/l/mg/dl, P = 0.9). These findings provide new evidence for the deleterious role of visceral fat in insulin resistance, and suggest that a greater OM procedure may effectively improve insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214178      PMCID: PMC3417107          DOI: 10.1038/oby.2008.642

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  28 in total

1.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 2.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.

Authors:  J P Després; S Moorjani; P J Lupien; A Tremblay; A Nadeau; C Bouchard
Journal:  Arteriosclerosis       Date:  1990 Jul-Aug

3.  Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha?

Authors:  M Shibasaki; K Takahashi; T Itou; S Miyazawa; M Ito; J Kobayashi; H Bujo; Y Saito
Journal:  Diabetologia       Date:  2002-04       Impact factor: 10.122

4.  High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats.

Authors:  K Nagy; J Levy; G Grunberger
Journal:  Acta Endocrinol (Copenh)       Date:  1990-03

5.  A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding.

Authors:  A Thörne; F Lönnqvist; J Apelman; G Hellers; P Arner
Journal:  Int J Obes Relat Metab Disord       Date:  2002-02

Review 6.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

Authors:  G Boden; G I Shulman
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

7.  Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.

Authors:  A Carpentier; S D Mittelman; R N Bergman; A Giacca; G F Lewis
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

8.  Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity.

Authors:  J Jimenez; S Zuniga-Guajardo; B Zinman; A Angel
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

9.  Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

Authors:  Ilan Gabriely; Xiao Hui Ma; Xiao Man Yang; Gil Atzmon; Michael W Rajala; Anders H Berg; Phillip Scherer; Luciano Rossetti; Nir Barzilai
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

10.  Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates.

Authors:  D T Finegood; R N Bergman; M Vranic
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

View more
  24 in total

1.  Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.

Authors:  Elisa Fabbrini; Robyn A Tamboli; Faidon Magkos; Pamela A Marks-Shulman; Aaron W Eckhauser; William O Richards; Samuel Klein; Naji N Abumrad
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

2.  Large size cells in the visceral adipose depot predict insulin resistance in the canine model.

Authors:  Morvarid Kabir; Darko Stefanovski; Isabel R Hsu; Malini Iyer; Orison O Woolcott; Dan Zheng; Karyn J Catalano; Jenny D Chiu; Stella P Kim; Lisa N Harrison; Viorica Ionut; Maya Lottati; Richard N Bergman; Joyce M Richey
Journal:  Obesity (Silver Spring)       Date:  2011-08-11       Impact factor: 5.002

3.  Mesodermal developmental gene Tbx15 impairs adipocyte differentiation and mitochondrial respiration.

Authors:  Stephane Gesta; Olivier Bezy; Marcelo A Mori; Yazmin Macotela; Kevin Y Lee; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 4.  Aging and adipose tissue: potential interventions for diabetes and regenerative medicine.

Authors:  Allyson K Palmer; James L Kirkland
Journal:  Exp Gerontol       Date:  2016-02-26       Impact factor: 4.032

5.  Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial.

Authors:  Troy H Dillard; Jonathan Q Purnell; Mark D Smith; William Raum; Dennis Hong; Jamie Laut; Emma J Patterson
Journal:  Surg Obes Relat Dis       Date:  2011-10-19       Impact factor: 4.734

6.  Inflammation and the depot-specific secretome of human preadipocytes.

Authors:  Yi Zhu; Tamara Tchkonia; Michael B Stout; Nino Giorgadze; Libing Wang; Peter W Li; Carrie J Heppelmann; Anne Bouloumié; Michael D Jensen; H Robert Bergen; James L Kirkland
Journal:  Obesity (Silver Spring)       Date:  2015-04-10       Impact factor: 5.002

Review 7.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

8.  Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial.

Authors:  Miguel F Herrera; Juan Pablo Pantoja; David Velázquez-Fernández; Javier Cabiedes; Carlos Aguilar-Salinas; Eduardo García-García; Alfredo Rivas; Christian Villeda; Diego F Hernández-Ramírez; Andrea Dávila; Aarón Zaraín
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

9.  Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats.

Authors:  Karyn J Catalano; Darko Stefanovski; Richard N Bergman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.